Wednesday, February 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Scout Stock: Surges on Upbeat Forecast Revision

Felix Baarz by Felix Baarz
August 5, 2025
in Stocks
0
Scout Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Berlin-based real estate marketer Scout24 has significantly raised its annual forecast, pleasantly surprising investors. Initially projecting 12–14% revenue growth, management now targets 14–15%, fueled by robust first-half performance. Revenue soared 15.5% to €318.2 million, with organic growth hitting 11.6%, signaling strength beyond acquisitions. Profitability outpaced expectations: adjusted EBITDA jumped 17.3% to €195.4 million, driving the margin up 100 basis points to 61.4%. The company now anticipates a 70-basis-point EBITDA margin improvement, up from 50.

Market Reaction Defies Fundamentals

Despite the upbeat revisions, Scout24’s shares showed muted response, briefly dipping 0.25% before a slight recovery. The disconnect highlights market unpredictability, even as the firm’s dual strategy—subscription resilience and acquisition synergies—delivers. Full half-year results, due August 7, may offer further clarity. The raised inorganic growth contribution (now 3% vs. 2%) underscores successful integration efforts, reinforcing long-term optimism.

Ad

Scout Stock: Buy or Sell?! New Scout Analysis from February 4 delivers the answer:

The latest Scout figures speak for themselves: Urgent action needed for Scout investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 4.

Scout: Buy or sell? Read more here...

Tags: Scout
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
BP Stock

BP Stock: Resilient Earnings Meet Major Oil Discovery

Brooks Automation Stock

Brooks Automation Stock: Mixed Q3 Results Spark Volatility

DHL Stock

DHL Stock: Defying Trade Headwinds with Strong Q2 Growth

Recommended

Clarius Group LLC’s Acquisition of Warner Bros. Discovery: A Leap of Confidence in the Future of Media and Entertainment

3 years ago
CureVac Stock

CureVac Investors Face Pivotal Week as BioNTech Takeover Hangs in the Balance

2 months ago
Block H&R Stock

H&R Block Shares Face Persistent Downward Pressure

4 months ago
Timberland Stock

Timberland Stock: Executives Cash In Near Peak Prices

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

QuantumScape Investors Await Critical Milestones After Share Price Decline

Chevron Shares Maintain Momentum Amid Record Production and Dividend Growth

UBS Shares Slide Despite Strong Earnings: A Closer Look at Investor Concerns

Trending

NextGen Healthcare Stock
Analysis

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

by Robert Sasse
February 4, 2026
0

NextGen Healthcare continues to demonstrate robust market strength, underscored by a key new client partnership and a...

Arcus Biosciences Stock

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

February 4, 2026
National Healthcare Stock

National Healthcare’s Financial Report: A Crucial Test Approaches

February 4, 2026
XRP Stock

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

February 4, 2026
Coinbase Stock

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum
  • Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback
  • National Healthcare’s Financial Report: A Crucial Test Approaches

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com